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Globally, populations are ageing, with an associated 
increase in the global chronic illness burden (The Lancet, 
Global Health Metrics, 2017). This implies longer illness 
trajectories and more need for medical decision-making 
across the illness trajectory and at end of life. In this con-
text, there has been growing interest in advance care 
planning (ACP). ACP is a voluntary process of reflection 
and discussion, usually undertaken with the support of a 
health or care professional, concerning goals and prefer-
ences for future care (Rietjens et al., 2017). ACP can be 
undertaken at any time but is especially relevant for those 
living with chronic and progressive illness and has been 
widely recommended as an integral part of chronic and 
long-term care (The Lancet, Global Health Metrics, 2017; 
Prince et al., 2016; Hall et al., 2011). ACP discussions are 
generally documented to inform care in the event of loss 
of capacity. In the United States (US), for example, advance 
directives (living wills) are used to set out treatment pref-
erences, broader goals and values and to assign Durable 
Power of Attorney. In England, advance statements set 
out general preferences, while advance decisions specify 
treatment refusals. Lasting Power of Attorney for Health 
and Welfare can also be assigned. While legal frameworks 
and terminology differ, similar provisions exist in Canada, 
 Australia, New Zealand and numerous other countries.
In research, ACP has been associated with fewer emer-
gency admissions, hospitalizations, burdensome treat-
ments and hospital deaths, as well as reduced hospital 
costs, greater concordance of treatment with patient pref-
erences and improved carer satisfaction (Dixon et al., 2015; 
Brinkman-Stoppelenberg et al., 2014). However, provision 
'L[RQ-DQG.QDSS0'HOLYHULQJ$GYDQFH&DUH3ODQQLQJ6XSSRUWDW
6FDOH$4XDOLWDWLYH,QWHUYLHZ6WXG\LQ7ZHOYH,QWHUQDWLRQDO+HDOWKFDUH
2UJDQLVDWLRQV-RXUQDORI/RQJ7HUP&DUHSSbۇ
/RQGRQ6FKRRORI(FRQRPLFVDQG3ROLWLFDO6FLHQFH*%
&RUUHVSRQGLQJDXWKRU-RVLH'L[RQMHGL[RQ#OVHDFXN
5(6($5&+
'HOLYHULQJ$GYDQFH&DUH3ODQQLQJ6XSSRUWDW6FDOH
$4XDOLWDWLYH,QWHUYLHZ6WXG\LQ7ZHOYH,QWHUQDWLRQDO
+HDOWKFDUH2UJDQLVDWLRQV
-RVLH'L[RQDQG0DUWLQ.QDSS
&RQWH[W*OREDOO\SRSXODWLRQVDUHDJHLQJZLWKSHRSOHLQFUHDVLQJO\OLNHO\WRGLHZLWKFKURQLFSURJUHVVLYH
LOOQHVV,QWKLVFRQWH[WWKHUHLVZLGHVSUHDGLQWHUHVWLQDGYDQFHFDUHSODQQLQJ$&3ZKHUHSHRSOHDUH
VXSSRUWHGWRWKLQNDERXWDQGH[SUHVVSUHIHUHQFHVFRQFHUQLQJWKHLUIXWXUHFDUH+RZHYHUWRGDWHWKHUH
KDVEHHQOLPLWHGV\VWHPDWLFLPSOHPHQWDWLRQ
2EMHFWLYHV,QDSXUSRVLYHVDPSOHRILQWHUQDWLRQDOKHDOWKDQGFDUHRUJDQLVDWLRQVZRUNLQJWRSURYLGH
V\VWHPZLGH$&3VXSSRUWZHH[DPLQHGRUJDQLVDWLRQDODLPVOHDGHUVۍSHUVSHFWLYHVRQWKHHFRQRPLFFDVH
DQGSURPLVLQJDSSURDFKHVIRUHᒍFLHQWO\GHOLYHULQJ$&3VXSSRUWDWVFDOH
0HWKRGV,QGHSWKTXDOLWLYHLQWHUYLHZVDYHUDJHLQHDFKRUJDQLVDWLRQZLWKOHDGHUV$&3VSHFLDOLVWV
DQGIURQWOLQHVWDᒊ
)LQGLQJV2UJDQLVDWLRQDODLPVIRU$&3VXSSRUWZHUHPXOWLSOHDQGFRPSOH[WKH\LQFOXGHGRSWLPL]LQJSDWLHQW
DQGIDPLO\FDUHVXSSRUWLQJVWDᒊDQGPLWLJDWLQJULVNVRIFRPSODLQWVIURPEHUHDYHGIDPLOLHVUHSXWDWLRQDO
GDPDJHSRRUVWDᒊPRUDOHDQGSRWHQWLDOOHJDOFKDOOHQJHV7KHHFRQRPLFFDVHFRPSULVHGLQWULQVLFEHQHᒋWV
IRUSDWLHQWVIDPLOLHVDQGVWDᒊDYHUWLQJFRVWVDVVRFLDWHGZLWKSRWHQWLDOULVNVDQGPDNLQJEHVWXVHRI
UHVRXUFHVE\UHGXFLQJUHDFWLYHFDUHDQGSURYLVLRQRIXQZDQWHGORZYDOXHWUHDWPHQWV$GHJUHHRIVWDᒊ
VSHFLDOLVPWHDPEDVHGGHOLYHU\XVHRIGHFLVLRQDLGVJURXSEDVHGIDFLOLWDWLRQVSXEOLFKHDOWKDSSURDFKHV
DQGVXSSRUWLYHSDUDOOHOV\VWHPFKDQJHVDQGLQLWLDWLYHVDSSHDUOLNHO\WRVXSSRUWWKHHᒍFLHQWDQGHᒊHFWLYH
GHOLYHU\RI$&3VXSSRUWDWVFDOH
/LPLWDWLRQV:HUHFUXLWHGRUJDQLVDWLRQVXVLQJVQRZEDOOVDPSOLQJ4XDQWLWDWLYHLQIRUPDWLRQZDVLQTXLUHG
DERXWWRFRPSOHPHQWGDWDIURPLQWHUYLHZVEXWDYDLODELOLW\ZDVOLPLWHG
,PSOLFDWLRQV$&3VXSSRUWPD\EHXVHIXOO\XQGHUVWRRGDVERWKDQLQGLYLGXDODQGV\VWHPOHYHOLQWHUYHQWLRQ
:HLGHQWLI\YDULRXVDSSURDFKHVIRUGHOLYHULQJ$&3VXSSRUWPRUHHᒍFLHQWO\DWVFDOH
.H\ZRUGVDGYDQFHFDUHSODQQLQJFKURQLFFRQGLWLRQVFKURQLFLOOQHVVPXOWLPRUELGLW\HQGRIOLIHFDUH
GHPHQWLDSHUVRQDOL]DWLRQSRSXODWLRQKHDOWKFRVWHᒊHFWLYHQHVVKHDOWKHFRQRPLFV
Dixon and Knapp: Delivering Advance Care Planning Support at Scale128  
of ACP support, particularly facilitation of ACP conversa-
tions, is demanding of staff time, with this widely consid-
ered a significant barrier to implementation (Dixon and 
Knapp, 2018; Fritz et al., 2017; Lund et al., 2015; Hagen 
et al., 2015; van der Steen, 2013; Sharp et al., 2013; Seymour 
et al., 2010).
Existing research evidence about implementing ACP 
is limited and fragmented. It has tended to focus on the 
identification of barriers (Occhipinti and Ramos, 2018; 
Lund et al., 2015; Hagen et al., 2015; Lovell and Yates, 
2014; van der Steen, 2014; Sharp et al., 2013; Robinson 
et al., 2013; Seymour et al., 2010). Studies are also com-
monly small-scale intervention studies in specific settings, 
usually with ACP facilitators selected and prepared by 
researchers (Lund et al., 2015) or small-scale focus group 
studies exploring the views and experiences of health and 
care professionals (Sharp et al., 2018; Fletcher al, 2016; 
Robinson et al., 2013; Gott et al., 2009). Research taking 
an organisational perspective or examining real-world 
provision of ACP support at scale, such as our study, is cur-
rently lacking (Jimenez et al., 2018; Hagen et al., 2015).
This study is an exploratory (contextual), qualitative 
interview study (Ritchie et al., 2013) conducted with lead-
ers and front-line health and care staff in 12 international 
healthcare organisations, each aiming to provide system-
wide ACP support. The research aims were to
•	 describe the types of staff and other resources em-
ployed in the provision of ACP support;
•	 understand organisations’ aims and objectives for in-
vesting in system-wide ACP support, including  leaders’ 
perspectives on the economic case;
•	 identify scope for efficiencies in the delivery of ACP 
support at scale, particularly facilitation of ACP con-
versations.
Methods
Study design
A qualitative approach was adopted to elicit provider per-
spectives and explore first-hand experiences of develop-
ing and delivering ACP support. Initial scoping identified 
limited availability of relevant quantitative (e.g., cost or 
activity) data.
Sampling and recruitment
A two-stage purposive sampling process was adopted, cov-
ering healthcare organisations and staff within these. For 
the first stage, we sought health and care organisations 
from any country with ‘well-established, system-wide ACP 
support provision’. In practice, these ranged from a sin-
gle condition programme to a publicly-funded healthcare 
region but commonly involved acute care provision along-
side primary and community care, as well as engagement 
with adjoining systems, such as long-term residential care 
providers and the voluntary sector (Table 1). We use the 
term ‘organisation’ throughout to refer to the providing 
or supporting healthcare organisation and ‘system’ when 
referring to the wider eco-system of organisations and 
providers through which patients and families access and 
engage with ACP support.
For sampling, ‘ACP support provision’ was defined as 
helping patients and members of the public find out 
about ACP, facilitating ACP conversations and assisting 
with completion of ACP documents. ‘Well-established’ 
was defined as provision of 18 months or longer. ‘System-
wide provision’ was defined as providing ACP support 
widely across all relevant services, sometimes including 
external partners. We also sought diversity against a range 
of secondary sampling criteria, including countries, small 
and large providers, rural and urban areas, care settings 
and ACP materials and approaches. We estimated that 
approximately 10 healthcare organisations would provide 
a sufficient range of experiences, enable diversity against 
secondary sampling criteria and provide a high level of 
site triangulation (Shenton, 2004; Cohen and Manion, 
2000). This number also allowed for potentially important 
differences between fieldwork sites to be identified and 
for similar issues to be explored from a range of perspec-
tives and contexts. It also helped to validate findings such 
that, where similar results emerged at different sites, find-
ings could be seen as having greater credibility (Shenton, 
2004). It additionally enabled us to provide respondents 
with greater anonymity, with the expectation of promot-
ing more candid, in-depth discussions.
Suitable healthcare organisations were identified, draw-
ing upon our own knowledge and through expert, net-
work and snowball sampling (appropriate where sample 
units are rare, hidden or where there is no available sample 
frame). While these approaches can generate sample units 
within closed systems, we deliberately approached experts 
with a wide view of international practice, attempted to 
create different start points, took an iterative approach, 
adopted multiple sampling strategies and sampled until 
no more cases likely to add sufficiently new information 
were identified (Cresswell and Plano Clark, 2017; Miles and 
Huberman, 1994). Experts included four members of the 
International Society of Advance Care Planning and End 
of Life Care (ACPEL, recently re-named ACP-international). 
We also conducted eight scoping interviews with end of 
life care experts in the UK, including representatives from 
the National Council of Palliative Care, Care England 
and the Association of Directors of Adult Social Services. 
Potentially, we may have missed relevant organisations 
outside of our networks. In particular, we may have identi-
fied organisations most active in ACP knowledge-exchange 
networks. However, arguably, these are likely to be organi-
sations with the most developed ACP support. In total, we 
recruited 12 healthcare organisations (Table 1).
Each organisation was approached directly, usually by 
email, through an appropriate senior staff member. This 
was followed with one or more telephone conversations 
with senior staff to explore eligibility and to discuss what 
participation would involve. All organisations received 
written information about the study. Once organisational 
and local ethical approvals were secured, we undertook 
the second stage of sampling.
Stage 2 involved sampling staff within each organisa-
tion, with a view to including a wide range of perspectives 
and achieving role triangulation (Tan et al., 2019; Shenton, 
2004; Cohen and Manion, 2000). A key contact in each 
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Table 1: Participating healthcare organisations.
Description of organisation How organisation was identified
United States
Gundersen Health A physician-led, not-for-profit healthcare system; birth-
place of Respecting Choices, an evidence-based ACP 
model for person-centered decision making.
Snowball sampling via Wisconsin Medical Society 
and known to the authors through the literature
Dartmouth-Hitchcock A non-profit, academic health system, providing ACP 
support using the Honoring Care Decisions ACP pro-
gramme (based on the Respecting Choices model).
Snowball sampling via Gundersen Health
Wisconsin Medical 
Society
A physician member association supporting 32 partici-
pating health organisations to implement the Honor-
ing Choices ACP programme (based on the Respecting 
Choices model).
Known to the authors through an earlier study 
they led into the economics of ACP
Sharp Healthcare A not-for-profit, integrated regional health care sys-
tem, providing ACP support in collaboration with the 
Coalition for Compassionate Care of California.
An academic expert identified through ACPEL* 
made an introduction to a regional coalition 
organisation that, in turn, made an onward intro-
duction to Sharp Healthcare. Sharp Healthcare 
and its Transitions program were also known to 
the authors through the literature
Canada
Northern Alberta 
Renal Program (NARP)
Renal programme in Edmonton, Alberta, providing 
integrated ACP support using an approach based on 
Conversations Matter.
Identified directly through a clinician, academic 
and member of ACPEL*
Fraser Health One of six publicly funded health care regions in Brit-
ish Columbia, providing ACP support in community, 
acute and residential care based on materials devel-
oped provincially and at Fraser Health Authority.
Northern Alberta Renal Program (NARP) made an 
introduction to an academic expert in Alberta 
who, in turn, made an onward introduction to 
Fraser Health
Australia
Austin Health A publicly-funded health service in Melbourne, provid-
ing acute, sub-acute, mental health and ambulatory ser-
vices, providing ACP support using materials developed 
locally and as part of Advance Care Planning Australia.
Identified directly through a clinician and mem-
ber of ACPEL*
Northern Health A publicly-funded provider of acute, sub-acute and 
ambulatory specialist services in Melbourne, providing 
ACP support using the ‘A-C-P in three steps’ approach 
developed within Northern Health.
Identified through snowball sampling via Austin 
Health
Barwon Health A publicly-funded, large regional health service, pro-
viding acute, sub-acute, elderly care, community 
health and mental health services, with ACP support 
delivered across secondary and primary care using 
materials, including MyValues, developed in Barwon 
Health.
Identified through snowball sampling via Austin 
Health
Albany Health A regional primary and secondary healthcare system, 
providing ACP support using forms developed by the 
Western Australian government and piloting systems 
for communication and access of ACP documents.
Identified through an academic and member of 
ACPEL* and through a contact identified by the 
authors in an earlier study they led into the eco-
nomics of ACP
New Zealand
The Canterbury 
 Initiative
A District Health Board initiative, delivering change 
and quality improvement initiatives across commu-
nity, primary and secondary care and providing ACP 
support using materials developed by the Canterbury 
Initiative and by the National ACP Cooperative, New 
Zealand.
A clinician and member of ACPEL* made an intro-
duction to the National ACP Cooperative who, 
in turn, made an onward introduction to the 
 Canterbury Initiative
Auckland District 
Health Board
A regional health authority overseeing community, 
primary and secondary care, providing ACP support 
using material developed by the National ACP Coop-
erative, New Zealand.
Identified through a clinician and member of 
ACPEL*
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organisation compiled a list of personnel with in-depth 
experience of developing or delivering ACP support and 
a range of others with routine experience. These included 
senior managers, dedicated ACP staff, physicians, nurses, 
social workers, volunteer staff and others. These lists were 
then narrowed, in consultation, with a view to balancing 
staff with different roles and for reasons of manageability 
or availability.
All identified staff were sent an introductory letter 
describing the study and what participation would involve. 
They were informed of the voluntary nature of partici-
pation and given the opportunity to opt out of further 
contact by emailing the key contact person in the organi-
sation or the research team. If they did not opt out, they 
were invited to interview. These were scheduled, for logis-
tic reasons, by the key contact. Participants were informed 
that they could withdraw at any time and were provided 
contact details for an independent person responsible 
for research ethics at LSE if they had concerns or queries 
about the conduct of recruitment or interviews.
Conduct of interviews
We conducted between 3–25 (average 13) interviews in 
each organisation during fieldwork visits undertaken 
November 2015 to May 2017 (Table 2). Most were indi-
vidual (n = 112), although, for practicality, 18 group inter-
views involving between 3–12 people were also conducted. 
Interviews lasted 20–180 minutes. Fully informed verbal 
consent was obtained at the beginning of each interview. 
Topic coverage was adapted to reflect the role and exper-
tise of interviewees, with people asked about their own 
role and experiences as well as their wider perspectives 
on the provision of ACP support in their organisations. 
Information provided in early interviews was cumulatively 
tested and further explored in later interviews. Interviews 
were audio-recorded with permission.
Data analysis and reporting
Audio-recordings were listened back to in full as soon as 
possible after the interview and a comprehensive, descrip-
tive written summary produced. Time-stamps were used 
to reference the audio-recordings, and potential quotes 
were included verbatim. Longer and more complex inter-
views were listened to on two or three occasions. Analytic 
notes were taken simultaneously. This process of data 
reduction is appropriate for analyzing large volumes of 
interview data in thematic analysis and supports compre-
hensive and systematic data handling (Ritchie et al., 2013). 
Data management thus also involved several stages, allow-
ing for considerable familiarization.
Data were then analyzed thematically using NVivo 
software (Ritchie et al., 2013). The theoretical orienta-
tion employed was pragmatic (Cresswell, 2018). Given 
the requirements of fieldwork, interviews and analysis 
were conducted primarily by a senior qualitative special-
ist (JD). A second senior researcher (MK) read a sample of 
interview summaries, commented on coding frames and 
provided regular critical input into evolving and final 
analyses, with any differences resolved through discussion 
and consensus. Feedback on coding frames and evolving 
analyses was also obtained in face-to-face meetings with 
a project advisory group. Descriptive analyses reported 
in this paper were checked for accuracy by the key con-
tacts in each organisation; no substantive changes were 
proposed. Quotes are identified throughout by country 
and professional role, differing slightly from categories in 
Table 2, to provide appropriate context while protecting 
respondent anonymity.
Results
Results are presented in three sections:
1.  Resources for delivering system-wide support pro-
vides context by describing the types of staff and 
other resources employed by organisations to pro-
vide system-wide ACP support.
2.  Organisational aims and objectives for providing 
system-wide ACP support explores organisational ra-
tionales for providing system-wide ACP support; sub 
sections consider 2.1) Patient and family care, 2.2) 
Health and care staff and 2.3) The Economic case.
3.  Delivering system-wide ACP support efficiently ex-
amines factors associated with variation in the time 
taken to facilitate ACP conversations and identifies 
promising approaches for efficient and equitable 
provision of ACP support at scale; sub-sections con-
sider 3.1.) Staff skills and experience, 3.2) Materials, 
guides and approaches and 3.3) Informational and 
educational needs of patients and families.
1. Resources for delivering system-wide ACP support
The primary resource used to deliver ACP support was staff 
time, covering strategic, specialist and generalist roles. 
While senior involvement varied between systems and 
over time, it was generally high, particularly during devel-
opment and implementation stages. In one US system, for 
example, an executive-level leader had devoted around 
30 hours over several months to oversee a review of ACP 
support provision, including several pilot studies. Internal 
performance improvement teams and externally commis-
sioned consultants also provided strategic support. Most 
organisations additionally employed full-time ACP leads 
(in two systems, senior academic physicians took this on 
as an adjunct role). Responsibilities included the develop-
ment of ACP resources, staff training and support, quality 
control, process improvements, external liaison and com-
munity outreach. ACP leads, particularly in larger systems, 
sometimes also oversaw community volunteers or worked 
with local community groups. In four of the larger health-
care systems in the US and Australia, between 2–4 dedi-
cated ACP facilitators were also employed, part-time, to 
facilitate ACP conversations and to coach other staff.
Across all organisations, within their existing roles, physi-
cians, nurses, social workers, care coordinators, occupational 
therapists, spiritual advisors and others provided day-to-
day ACP support directly to patients and their families and, 
sometimes, to others in the community. ACP conversations 
of sufficient quality and scope were thought, depending on 
complexity, to take 30–90 minutes, either in one or multi-
ple sessions. ACP staff were supported, in some instances, 
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Table 2: Interviews by healthcare system and respondent role.
Gundersen Dartmouth-
Hitchcock
Wisconsin 
Medical
Sharp NARP Fraser Austin Northern Barwon Albany Canterbury Auckland TOTAL
Senior managers/leaders 4 1 2 2 0 1 1 0 2 0 2 2 17
Dedicated ACP staff 2 3 3 3 0 1 4 1 3 0 3 1 27
Physicians 2 2 1 2 1 2 3 2 2 4 3 0 21
Nurses 3 2 5 1 8 6 0 0 1 3 5 3 37
Social workers 4 0 5 2 2 1 0 0 1 0 1 1 17
Other 10 6 1 2 1 5 4 0 2 2 3 2 38
TOTAL 25 14 17 12 12 16 12 3 12 9 16 9 157
Individual 19 1 7 12 12 16 12 1 6 9 10 7 112
Group 3 5 3 0 0 0 0 1 2 0 3 1 18
Notes:
•	 Respondents sometimes filled more than one role. In these cases, we have selected the primary role. For example, physicians with a full-time clinical position are categorized as physicians even if 
they are an ACP lead or hold other leadership roles.
•	 The category of physicians includes hospital physicians (including palliative care physicians, geriatricians and other specialists) and general practitioners.
•	 Dedicated ACP staff are those whose positions are exclusively or predominantly ACP-related.
•	 Other includes spiritual care advisors, volunteers, care home staff, speech therapists and occupational therapists.
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by administrators who scheduled appointments and 
checked and scanned completed ACP documents. Because 
ACP support was provided by different staff groups, often 
delivered with other care and broken into multiple shorter 
conversations and not separately recorded, no organisation 
was able to quantify the time spent by health and care staff 
delivering ACP support. While some of this work was poten-
tially absorbed into existing care, much was widely thought 
to be additional work. A companion article explores the dif-
ferent approaches taken by health and care staff to accom-
modate this work in their day-to-day roles, noting the 
significant challenges presented by time constraints (Dixon 
and Knapp, 2018). Total staff time spent receiving training 
could also be substantial, particularly where large numbers 
of staff were trained, with courses ranging in duration from 
one or twohours to two or three days.
Non-staff resources included training resources; these 
were provided nationally online, developed and delivered 
in-house, directly commissioned from external provid-
ers or delivered within existing continuing professional 
development provision. Materials such as conversation 
guides and forms varied in cost to the organisation deliv-
ering ACP. These were sometimes available from national 
or regional initiatives, usually free of charge; others were 
purchased, sometimes as part of wider support packages, 
or were developed or adapted internally. Where ACP sup-
port was provided as part of routine care, this took place 
in usual appointment rooms but otherwise took place 
in vacant consulting rooms and offices, at the hospital 
bedside, in people’s homes and in community settings. 
Adaptations and updates to existing electronic patient 
information systems were sometimes implemented to 
allow ACP conversations to be more readily recorded and 
documents retrieved. Respondents also identified variable 
costs associated with external promotion and outreach 
activities.
The costs of staff time and other resources for provid-
ing ACP support were met primarily from existing inter-
nal budgets. Governmental and other external sources of 
funding were sometimes available but largely for devel-
oping ACP infrastructure and for public engagement, 
rather than direct provision of ACP support. However, 
during the course of our study, new funding for facili-
tating ACP conversations was identified, including a new 
Medicare charging code in the US and flexible use of 
existing Medicare codes in Australia. In one New Zealand 
system, the District Health Board also incentivized gen-
eral practitioners (GPs) to complete plans for people 
in their last year of life. Initial take-up was slower than 
anticipated, largely due to GP time pressures. However, 
a change allowing nurses and social workers to facili-
tate conversations under GP supervision led to a steady 
increase in use of the incentive. Most leaders expected 
their organisations to sustain their commitment to pro-
viding system-wide ACP support with, occasionally, addi-
tional investments envisaged. Only exceptionally, in the 
context of budget cuts or less supportive funding con-
texts (e.g., fee for service) were investments in ACP sup-
port considered vulnerable.
2. Organisational aims and objectives for providing 
system-wide ACP support
The aims and objectives described by leaders for provid-
ing system-wide ACP support were complex and multiple. 
Overall, leaders discussed the provision of ACP support 
as a strategic response to a range of emerging challenges 
associated with an ageing population, higher levels of 
chronic illness and frailty and greater availability and use 
of potentially life-prolonging treatments in advanced 
 illness. These challenges, and the role of ACP in helping 
to mitigate them, are discussed in the following sections: 
(2.1) Patient and family care, (2.2) Health and care staff 
and (2.3) The economic case.
2.1. Patient and family care
The provision of system-wide ACP support was commonly 
discussed as a way of systematically improving patient and 
family care in the context of growing levels of chronic, 
progressive disease. In the absence of ACP support, such 
patients and families were often thought insufficiently 
prepared for eventual deterioration in their health condi-
tion and the medical decision-making likely to be associ-
ated with this.
Many patients are in a stable chronic state, but 
they need to understand that this stability will end. 
(Physician, Canada)
People could have unrealistic expectations concerning 
the care they were likely to receive in the future. Some 
assumed, for example, that they wouldn’t be offered or 
provided with aggressive treatments.
People don’t always understand that they are going 
to be treated, and possibly quite extensively, even 
as they get older and frail. (Physician, Australia)
Others expected to be provided with all and any available 
life-prolonging treatments, potentially overestimating the 
likely benefits while underestimating associated burdens 
and risks.
People’s expectations of healthcare are very high. 
People have come to see medicine as being the 
 fix-it for all sorts of things. (Physician, Australia)
Without appropriate knowledge and preparation, fami-
lies may also, particularly in the context of health crises, 
request everything is done for their relative.
Guilt and panic can lead people to opt for the default 
of wanting more and potentially inappropriate 
interventions; ‘I can’t let mom go without feeling 
I’ve done everything possible’ (Physician, Australia)
In the face of uncertainty, hospital physicians too were 
thought to err towards providing life-prolonging treat-
ments. They were thought to underestimate treatment 
burdens, had limited training in palliative and end of 
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life care and could be unsure about their legal respon-
sibilities to treat. As a result, marginal, and potentially 
unwanted, treatments were sometimes provided, with 
some respondents specifically identifying this as a medi-
cal consent issue.
It {ACP} is really important as we’re potentially talk-
ing about very burdensome treatments or treat-
ments with a risk of poor outcomes. For example, 
resus[citation] is such a bad treatment, so few peo-
ple do well, so I think you need consent for this. 
(Physician, Australia)
Importantly, without ACP support, people were generally 
unaware of their right to express preferences about how 
health and care decisions are taken or to refuse certain 
medical treatments.
People don’t know they can choose not to have 
treatment. They think they don’t and that’s eutha-
nasia. (ACP specialist, New Zealand).
In this context, systematic and routinised provision of ACP 
support was thought to help prepare patients and fami-
lies, clarify patients’ preferences and support profession-
als to personalize care and limit the use of low-value or 
potentially futile treatments.
Empowering doctors to say, you know, I am not 
going to insert a feeding tube in your 92-year-old 
grandma who has end-stage Alzheimer’s and mul-
tiple comorbidities. (ACP specialist, US)
It was also thought to help avert a range of associated 
organisational-level risks, including increases in the level 
of formal complaints, particularly from bereaved families 
dis-satisfied with their relative’s end of life care, and repu-
tational risks, politically and in the media. One respond-
ent in the US also saw potential for new legal challenges 
associated with the provision of unwanted treatments.
There was a recent article in the New York Times, 
‘The patient lived and the family sued.’ I think we 
will be seeing an increase in this. (ACP special ist, 
US).
2.2. Health and care staff
As a result of an increase in chronic progressive illness 
and greater need for medical decision-making at points 
of health crisis, health and care staff were thought to be 
increasingly at risk of conflictual and/or crisis-driven con-
versations with families.
As a tertiary provider, we have serious long-term 
and acute cases transferred, so we have that per-
spective and see what happens when people are 
unprepared; conflict between family members and 
between them and clinicians, residential care staff 
etc. (Leader, New Zealand)
Staff were also thought to be increasingly exposed to the 
risk of moral distress, particularly with regard to aggres-
sive medical treatments in advanced illness.
The default is always to provide aggressive care, so 
I was asked to do things I thought were ethically 
wrong and medically wrong. (Physician, US)
They think doctors are not stopping; nurses are 
thinking, ‘why is this treatment happening? (Physi-
cian, Australia)
At an organisational level, these pressures could lead to 
poor staff morale and related workforce management chal-
lenges. System-wide provision of ACP support was seen 
to mitigate these risks by promoting improved and more 
timely communication between professionals, patients and 
families and by reducing the pressure on physicians to pro-
vide marginal, low-value or potentially futile treatments.
2.3. The economic case
Organisational risks, such as complaints from families, 
reputational damage and poor staff morale, were also 
associated with unpredictable but potentially significant 
economic costs, which the systematic provision of ACP 
support was thought to help manage. It was also consid-
ered a way to make best use of resources, by redirecting 
staff time towards timely, rather than crisis-driven, inter-
actions with patients and families and by providing fewer 
unwanted, low-value medical interventions.
For a long while it’s about maintaining quality of 
life and living with illness, but then there is a time 
when it is about dying and diminishing returns and 
there are huge costs to get to tiny benefit … Most 
people have a threshold and we’re not identifying 
that point reliably. (Leader, Canada)
Consequently, some respondents thought that ACP sup-
port could help to reduce spending on end of life care in 
acute settings.
If just one person is not stuck in ICU [intensive care 
unit] for three months as a result, it’s easily paid for 
itself. (ACP specialist, US)
If you do it properly, suitably efficiently, it seems 
likely that there will be savings. There is evidence of 
oversupply, treatments people don’t want.  People are 
able to have a conversation and potentially withdraw 
from active treatment, will not be hospitalised; there 
must be savings attached. So, some of the challenge 
is establishing the quality indicators determining 
that this is also better for people. (Leader, Australia)
It was widely understood, however, that any savings 
needed to be set against the costs of making ACP sup-
port widely available and that costs were also likely to 
be incurred in providing alternative, community-based 
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 support. Some respondents also thought acute savings 
could be limited, with people preferring or needing, par-
ticularly where appropriate community-based care was 
lacking, to be admitted to hospital.
A lot of people want to die in hospital, that’s okay. 
It won’t necessarily save resources. (Physician, New 
Zealand)
The trouble we had was that we did try to meas-
ure costs, but if you opted out of aggressive care 
it wasn’t as though there was somewhere else you 
could go to, you still had come to hospital. (Leader, 
Australia)
Overall, there was no widespread expectation of overall 
cost savings and no organisation had identified economic 
outcomes or targets for its ACP support provision.
There is an economic argument but we aren’t inter-
ested in any financial outcomes. (ACP specialist, 
New Zealand)
ACP was also widely understood by leaders to be a com-
plex intervention, the full economic implications of 
which were necessarily difficult to measure. Leaders 
noted particular challenges in gathering accurate and 
comprehensive cost and activity data, placing economic 
value on quality improvements and determining causal 
associations.
It’s too cumbersome to get accurate costs figures 
because people would need to charge to the code 
and it’s more work than it’s worth, particularly 
because it cuts across departments and overlaps 
with other work. (Leader, US)
The health economics people we’ve worked with 
say what’s hardest is linking cause-and-effect in 
practice in a complex intervention like ACP. (Physi-
cian, Australia)
Scope for media and public misunderstandings could 
also limit discussion about the potential economic impli-
cations of ACP. To sustain investments, leaders wanted 
research evidence that demonstrated economic value 
(rather than cost-savings), including showing positive 
impacts for patients and families and reassurance con-
cerning potential harms. Leaders also wanted evidence 
about how ACP support could be delivered optimally, with 
an indication of the level of resource needed.
It would be good from my perspective, in order to 
ask for more resources, to validate the amount of 
resource that is required. (Leader, Australia)
The aim is to improve quality and efficiency, to 
make it leaner. It’s part of the culture. You know 
you need to do it. The hard part is knowing how 
much resource to put into it and how to put that 
resource into it. (Leader, US).
3. Delivering system-wide ACP support efficiently
Finally, we explored factors associated with variation, 
within and between systems, in the level of resource, nota-
bly staff time, used to provide ACP support. Through this, 
we were able to meet our third research objective of iden-
tifying scope for efficiencies in the delivery of ACP support 
at scale. In particular, we generated evidence around three 
main themes: (3.1) staff skills and experience, (3.2) mate-
rials, guides and approaches and (3.3) informational and 
educational needs of patients and families
3.1. Staff skills and experience
The experience and abilities of staff were widely consid-
ered key to the efficient, as well as effective, facilitation of 
ACP conversations.
If you’re good, it may only take about 45 minutes. 
There are other people who take two hours and 
come out just with medical power of attorney. (ACP 
specialist, Australia)
There are two parish nurses who do advance care 
planning with people in their homes. They’re effi-
cient; their ones are shorter, about 30 minutes. 
(Volunteer, US)
Leaders, however, described challenges in developing 
these competencies in their workforces. Existing medical 
training for physicians, for example, was identified as lack-
ing adequate coverage of communication skills or end of 
life care.
It does seem extraordinary that people who are 
dealing with really serious illness do not get too 
much education around end of life. Most people are 
currently learning on the job. If they’ve not had that 
really fully in their early education, and if you’re 
learning from someone who does it poorly, then 
that’s not good. (Leader, Australia)
To develop workforce skills, some organisations had previ-
ously provided in-depth training to substantial numbers 
of physicians, nurses and social workers, with the inten-
tion of embedding ACP widely in practice. However, many 
staff failed to apply and develop their skills in practice 
because of time constraints, perceptions that this work 
was not sufficiently acknowledged or supported in their 
departments or due to staff turnover.
We trained thirty-one, but only ten are active. The 
rest changed position or decided they couldn’t do 
it on top of their work. (Nurse, Canada)
They trained everyone but sitting down and talking 
to patients wasn’t always recognised. You might get 
people championing it for a while, but they would 
get tired or would move on. (Physician, Australia)
In some cases, staff were reluctant or lacked confidence 
and, once trained, either didn’t facilitate ACP conversations 
or did so less effectively and efficiently.
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People were put forward and volunteered for train-
ing. We trained people for two days and never 
heard any more from them. People turned up not 
knowing what they were there for. (ACP specialist, 
New Zealand)
It was pushed onto people who weren’t that com-
petent. It took ages and they struggled to do it. 
(Leader, Australia)
Staff could also find it hard to get enough practice, fol-
lowing their training, to develop and maintain their skills.
It was so was hard to get their skills up. They needed 
more experience. (Physician, Canada)
At the same time, there was wide agreement that reliance 
on a select group of dedicated ACP facilitators was neither 
scalable nor sustainable. In organisations that employed 
them, dedicated ACP facilitators could demonstrate ACP 
was acceptable and feasible in a clinical context and could 
provide support to other professionals. They were also 
independent of physicians, who patients might feel a need 
to please. However, they tended to take longer to facilitate 
a conversation, and ACP could be insufficiently integrated 
with the rest of a person’s care. They could also give phy-
sicians, nurses and others the impression that providing 
ACP support was not their responsibility. Organisations 
sometimes aimed to find a middle way. In one well-estab-
lished organisation, most staff were expected to introduce 
ACP and refer while a pool of 30–40 staff, primarily nurses 
and social workers, were trained to undertake ACP con-
versations. These staff worked with their managers to find 
the additional time needed to accommodate this work 
alongside their day-to-day roles.
Views concerning the amount of initial training needed 
also varied. Longer training sessions, of two to three days, 
ensured sufficient topic coverage and skills development, 
including opportunities to practice facilitation. However, 
some respondents thought shorter sessions, from two 
hours to a day, were sufficient, as well as more realistic 
and less off-putting for those with no previous experience 
of ACP. It was suggested follow-up training could be pro-
vided to those who would go on to conduct ACP conver-
sations regularly or who wanted to develop specialisms, 
such as working with people with specific diagnoses.
3.2. Materials, guides and approaches
A wide range of ACP approaches and guides were 
employed in the organisations engaged in this study (see 
Appendix 1). A range of government and state forms were 
also in use. None of these specifies the length of an ACP 
conversation, while materials and guides range from com-
prehensive and structured to short and flexible. The ben-
efits of more comprehensive and structured guides were 
they included tried and tested questions and processes, 
encouraged consistency and were thorough.
We need to do enough at the front end to work out 
what they really mean and what they understand. 
(Leader, US)
However, others found such approaches to be compli-
cated, inflexible or unhelpfully inclusive.
Some of the questions can be patronizing, repeti-
tive and unnecessary. They didn’t know why we 
were going through the same things again. (Social 
worker, US)
We want to ensure we are not saturating the docu-
ment with so much information it becomes too 
much and paralyses us. (ACP specialist, US)
They were also considered less amenable to being broken 
down into shorter, more opportunistic conversations.
The kinds of things that came back are ‘it’s too 
complicated’, ‘they didn’t have the time’. And 
there was a sense that if you start you have to 
go the whole way. People were daunted by that. 
(Physician,  Australia)
However, in practice, we found more comprehensive and 
structured guides were often used flexibly or selectively and 
conversations using these, particularly when led by expe-
rienced staff, generally took no longer than those under-
taken with shorter, more flexible guides. Shorter and more 
flexible guides were also not intended to, nor did they, nec-
essarily result in significantly shorter conversations.
Two new approaches were mentioned, however, as 
potentially having cost-efficiency benefits: Ariadne Lab’s 
Serious Illness Conversation Guide and a group facilita-
tion model based on Respecting Choices®. The Serious 
Illness Conversation Guide was designed to help non-
palliative physicians integrate basic elements of palliative 
care, including ACP, into their practice.
It is discrete, do-able. The training is two and a half 
hours. Most people can manage that. The conversa-
tion is 20-minutes. Most people can think about 
doing that. (Leader, Canada)
While considered highly valuable for engaging clinicians, 
particularly busy consultant physicians, the guide is, 
however, intended for advanced illness. There was, conse-
quently, concern that, unless built upon earlier ACP-style 
discussions, patients and carers may be poorly positioned 
to participate meaningfully in them.
If you’ve just got a diagnosis, serious illness conver-
sations may not apply yet. (ACP specialist, Canada)
Some say this is 20 mins. I don’t think a 20-minute 
conversation is realistic. They’re not meant to be 
yes, no answers. (Physician, Canada)
It is helpful if they’ve done advance care planning 
beforehand as then there is more to hang your hat 
on. (Physician, New Zealand)
Group facilitations based on Respecting Choices® were 
described as lasting around an hour, with 4–12 attendees, 
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sometimes including family members. One, sometimes 
two, trained facilitators led the groups, with time for 
questions and discussion. In the two organisations using 
this approach, the groups were popular. Participants were 
reported as feeling less obliged to complete ACP docu-
ments than in one-to-one discussions and to value the 
peer sharing aspect.
The group works well for some people because they 
hear what other people say and it enriches their 
experience of the discussion. (Social worker, US)
Facilitators ran groups on a regular basis and developed 
expertise in this approach. In one US-based system, for 
example, eight nurse health coaches from primary care 
clinics each led a monthly group. Participants could com-
plete documents immediately afterwards, assisted by a 
facilitator, or book a one-to-one ACP conversation. Pro-
viders estimated that 25–50% of participants completed 
documents and around 5% booked a follow-up ACP con-
versation. We found examples of groups involving the 
general public, people just having received diagnoses and 
disease-specific groups.
Disease-specific groups are a really good model; 
they’re all facing similar issues. I don’t find people 
are reluctant to discuss their issues in the group. 
Those who don’t want to talk about themselves will 
just sit and listen. (ACP specialist, US)
The approach was thought to increase reach and to be 
a cost effective and equitable means of providing ACP 
support.
Our groups have been fabulous so far. They have 
allowed us to serve more people with less resources. 
(ACP specialist, US)
3.3. Informational and educational needs of patients and 
families
Finally, respondents repeatedly described the informa-
tional and educational needs of patients and families as 
being a significant influence on the amount of time needed 
for an ACP conversation. ACP was often a new concept for 
people, and it could take time to explain its purpose and 
scope.
What can make it take a long time is their  ability to 
understand what it’s all about. (Nurse, New  Zealand)
Patients and families often needed clarification and reas-
surance about the legal and formal aspects of ACP. They 
sometimes also had a poor understanding of their con-
dition, necessitating more conversation time and/or 
physician referral. Considerable time could also be spent 
explaining the implications of specific treatments, such 
as cardio-pulmonary resuscitation (CPR), assisted venti-
lation, clinically-assisted nutrition and clinically-assisted 
hydration.
Can get into circular, murky CPR conversations. They 
don’t believe you. They want to have it first so they 
aren’t dead. It’s hard to get people to understand only 
4% will be alive. This takes time. (Social worker, US)
ACP raises a lot of questions, things like, ‘what if I 
faint, will I not be helped if I’ve said no to CPR?’ sort 
of thing. This takes explaining. (Nurse, Australia)
People have a lot of questions about nutrition and 
it can take up a lot of the conversation. (ACP spe-
cialist, US)
Some staff, particularly social workers and others with lim-
ited clinical backgrounds, found using decision aids useful 
to help simplify and standardise these conversations.
It’s a pictorial decision aid; gives you information 
that’s hard to explain otherwise. (Social worker, 
Canada)
We may well end up going down the road of using 
decision aids; there is a company that have some 
really sleek and useful health decision aids. Also, 
you don’t know what information physicians are 
giving. You like to believe that they are giving 
standardised, credible information, but you don’t 
know. (Leader/physician, US)
People also often had questions about the process of 
dying that had not been addressed elsewhere and often 
had only limited awareness of palliative treatments.
People want to know if they’ll be in pain, worried 
they won’t be conscious and in control. Issues 
around difficulties breathing and feeding are not 
well understood, and they don’t know about the 
things that can be done palliatively; there’s been 
lots of progress. (GP, Australia)
Some participants needed support across many or all of 
these areas, and these conversations could be particularly 
lengthy.
They may have poor understanding, say, of CPR. 
May not know what they want or who should be the 
agent. It can be a lengthy discussion just trying to 
explain things, an hour to an hour and a half. At that 
stage I suggest they go home and reflect. Repeated 
appointments are not unusual. (Nurse, US)
Where people, and their families, had attended commu-
nity-based education or events or undertaken other prep-
aration, particularly earlier on in the disease trajectory, 
ACP conversations could be much shorter.
If they are prepared it can be quick. We will have 
sent information; some will read it and some won’t. 
(ACP specialist, Australia)
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The good thing about drawing people in through 
education, outreach and community presentations 
is that they will have already thought through some 
of the questions and discussions. It will, therefore, 
be less protracted. (Social worker, US)
It’s really hard getting people to think about this 
stuff. The first time is often when they are acutely 
unwell. They need to start educating people along 
the journey, along the way. (Physician, Australia)
While it was thought important that people had sufficient 
and equitable access to high-quality ACP support, some 
thought it an inappropriate use of resources for staff to 
spend considerable time in individual ACP conversations 
attempting to elicit clear preferences from those who 
remained indifferent, undecided or wished professionals 
to make these choices.
Discussion
ACP is emphasised in national policy in many countries 
within the context of rapid population ageing and increas-
ing chronic illness burden (Prince et al., 2016; Institute of 
Medicine, 2014). However, the demands on staff time of 
providing ACP, particularly at scale, are widely understood 
to be a significant barrier to implementation (Dixon and 
Knapp, 2018; Fritz et al., 2017; Lund et al., 2015; Hagen et 
al., 2015; van der Steen, 2013; Sharp et al., 2013; Seymour 
et al., 2010). The resourcing of ACP support provision 
at scale remains, therefore, an important evidence gap. 
In particular, our study directly responds to calls in the 
literature to move beyond small-scale pilots and to con-
sider how ACP support may be provided and resourced at 
a whole organisation and/or system level (Jimenez et al., 
2018; Hagen et al., 2015). In particular, we set out to under-
stand how leaders working to provide ACP support across 
their organisations, and commonly also into adjoining 
systems, justified their investments, as well as to explore 
their perspectives on the economic case. We also aimed to 
gain insights from leaders and practitioners into ways of 
delivering ACP support efficiently and equitably at scale. 
We found many common challenges and experiences with 
some limited differences associated with the relative size 
of the organisation and population served, the maturity 
of ACP support provision, availability of different types of 
staff and, occasionally, specific or innovative approaches. 
We discuss the implications of our findings in two parts: 
organisational aims and objectives and the economic case 
and delivering system-wide ACP efficiently at scale.
Organisational aims and objectives and the 
economic case
Leaders identified multiple, inter-related organisational 
aims and objectives, raising questions about how ACP 
support is most usefully conceived and about the research 
outcomes that are most relevant (Jimenez et al., 2018; 
Gilissen et al., 2018; Sudore et al., 2018; Dixon et al., 2015). 
Researchers, to date, have primarily conceived of ACP as 
a means of promoting patient autonomy, with some 
research focused also on how ACP impacts the utilisation 
of acute healthcare (as a proxy for reductions in unwanted 
treatments) (Brinkman-Stoppelenburg et al., 2014; Dixon 
et al., 2015). Leaders and other respondents in our study 
emphasised the role of ACP in supporting patient choice 
and control over the type of care received in advanced ill-
ness, with many seeing ACP as key to ensuring people did 
not receive unwanted treatments, and this was identified 
specifically as a medical consent issue. However, improved 
communication with family members was also identi-
fied as an important objective, with a view to improving 
families’ experiences, reducing moral distress for families 
and, at an organisational level, mitigating risks of formal 
complaints from family members, reputational damage 
and potential legal challenge. In the ACP literature, there 
is some focus on the role of family members in end of 
life decision-making, particularly in dementia (Brazil et 
al., 2018; Harrison-Dening et al., 2016; Davies et al., 2014) 
and some theoretical literature, for example, around ACP 
and relational autonomy (Johnson et al., 2018; Ikonomidis 
and Singer, 1999). However, there is undoubtedly greater 
scope for developing these areas of research and for con-
sidering how to better support the families of people with 
serious illness and frailty in the context of increasingly 
complex decision-making about treatment and care. In 
addition, leaders intended for the systematic provision of 
ACP support to help create a more supportive culture and 
environment for health and care staff. As well as enabling 
them to limit the provision of low-value or potentially 
futile interventions, it was expected that ACP could help 
to reduce experiences of conflict in interactions with fami-
lies, workplace stress and the potential for moral distress 
(Oliver, 2018; Pauly et al., 2012). This, in turn, was seen 
to contribute to more effective workforce management at 
an organisational level. So far, research into the provision 
of ACP support has tended to focus on the challenges for 
staff of implementing ACP (Dixon and Knapp, 2018; Lund 
et al., 2015). However, there is likely scope for researchers 
to explore the potential benefits of ACP, both for individ-
ual staff members and at a workforce level.
Leaders in our study saw an economic case for system-
atically offering ACP support, with this an important 
aspect of retaining organisational support for invest-
ments. However, the economic case primarily focused on 
realising economic value rather than cost-savings. This 
included the intrinsic benefits to patients, family and 
staff discussed above, with this particularly important to 
those working within population health systems, who 
needed to demonstrate value in terms of prevention and 
improvements in population well-being (Buck et al., 2018; 
Alderwick et al., 2016). The economic case also included 
making better use of resources by reducing reactive use 
of staff time and limiting low-value treatments. It also 
included mitigating potentially significant economic risks 
associated with increased complaints, reputational dam-
age, legal challenges associated with perceived over- and 
under-treatment, workforce stress and low staff morale.
Some saw the potential for cost savings in acute settings, 
which is a view supported by a small number of existing 
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outcome studies (Dixon et al., 2015). However, overall 
cost savings were generally not expected and no organi-
sation had economic targets. Leaders also commonly 
thought that, even if there was the potential for modest 
savings, these would be difficult to identify, measure, 
attribute and, in the short to medium term, operationally 
realize or redirect. Although not directly mentioned by 
respondents, we also know there are complex, dynamic 
and longer-term economic (and quality of life) impacts 
associated with medical decision-making in serious ill-
ness, some of which will fall to health and care providers 
in future, further complicating the economic case (Gross 
et al., 2018). In light of this complex picture, while leaders 
had some interest in research illuminating the economic 
case, they were more immediately interested in research 
demonstrating ACP support is good for patients and their 
families and for clarifying and offering ways to minimise 
possible harms. They also wanted evidenced-based assess-
ments of how to deliver ACP optimally, an area in which 
there are currently significant gaps in our understanding, 
and for these assessments to include an indication of the 
resources required (Jimenez et al., 2018).
Overall, our findings emphasised complexity (Gilissen 
et al., 2018), a multiplicity of desired outcomes and 
stakeholders (Jimenez et al., 2018) and ACP support as a 
 system- as well as individual-level intervention (Jimenez 
et al., 2018; Hargreaves, 2010). In this context, the pro-
vision of system-wide ACP support is also just one of a 
range of, potentially inter-dependent, strategic actions 
and structural changes that may be needed to address 
the same underlying pressures, brought about by an age-
ing population and the increasing prevalence of chronic 
progressive illnesses (Johnson et al., 2017). These may 
include greater personalization, the implementation of 
public health approaches and more focus on intermedi-
ate and community-based care; new funding and delivery 
models, such as population health approaches, which 
incentivise prevention and improvements in well-being 
for a target population over volume of care (Buck et al., 
2018; Alderwick et al., 2016); and improved awareness and 
availability of supportive and palliative care (Campbell 
and English, 2016; Dixon et al., 2015). Changes in medi-
cal training and culture are also likely to be important, 
including improved coverage of communication skills and 
end of life care in basic medical training (Head et al., 2016; 
Gibbins et al., 2011), improved physician skills in assessing 
and communicating the respective benefits and harms of 
treatments (Hoffmann et al., 2017) and improved end of life 
care skills within nursing homes (Anstey et al., 2016). The 
Serious Illness Conversations training and guide, referred 
to by some of our respondents, is also pertinent here 
(Bernacki et al., 2015). Additionally, further development 
of initiatives designed to minimize burden and harm from 
over-investigation and overtreatment, such as Choose 
Wisely (US), Speak Up, (Canada), Rethinking Medicine (UK) 
and Realistic Medicine (Scotland), are relevant (Gross et al., 
2018). At the same time, while the provision of ACP support 
may be one element in a wider series of related structural 
interventions and developments, it retains a unique role, 
providing a means for individuals to consider and express 
preferences concerning their future care in a context in 
which high-risk, high burden treatments are increasingly 
available and provided in the late stages of illness.
Delivering system-wide ACP efficiently at scale
Delivering ACP support efficiently was identified by lead-
ers in our study as important for viability and equity and 
important for justifying additional investments. Although 
offering ACP support was seen to be inherently resource-
intensive, we identified several areas in which meaningful 
efficiencies may be sought. Firstly, we found that staff who 
were skilled and experienced at facilitating ACP conver-
sations were most efficient, while those who undertook 
ACP irregularly, were reluctant or lacked confidence were 
widely thought to take much longer and to achieve less. 
This finding adds to existing debates in the literature about 
whether ACP should be facilitated by dedicated facilita-
tors or by health and care staff within their existing roles 
( Pollock and Wilson, 2015; Lund et al., 2015; Hammes et 
al., 2012). Having professionals incorporate ACP into usual 
care has been a common policy preference for reasons of 
perceived efficiency and continuity of care. However, we 
(in a companion paper) and others have found, using this 
approach, ACP can get squeezed out or become unhelp-
fully fragmented, roles and responsibilities can be unclear 
and sufficient physician input can be lacking (Dixon and 
Knapp, 2018; Lund 2015; Robinson et al., 2013;  Sampson 
et al., 2010). Findings from the current study further sug-
gest even when professionals do deliver ACP support 
within their existing roles, they are likely to facilitate 
conversations infrequently and less efficiently. In-depth 
training is also harder to target where facilitating ACP con-
versations is a general responsibility. Our findings, there-
fore, point to the need for a degree of specialism ( Pollock 
and Wilson, 2015). At the same time, existing research 
(including our own, in a companion paper) suggests that a 
cadre of dedicated ACP facilitators is not sustainable, not 
likely to optimize efficiency or effectiveness and may lead 
to ACP being unintegrated with other care (Dixon and 
Knapp, 2018; Occhipinti and Ramos, 2018; Lund et al., 
2015). Overall, then, the evidence suggests models that 
balance continuity of care with skilled, efficient delivery 
are required. In one US-based organisation, for exam-
ple, a pool of specially trained nurses and social workers 
were available for referrals, usually from physicians, with 
time set aside in their schedules for this work. In other 
organisations, this balance was achieved by GPs and other 
physicians working closely with specially trained nurses 
and social workers in their own teams (Dixon and Knapp, 
2018). Such team-based approaches are also consistent 
with many new models of care, including patient-centred 
medical homes and primary care homes (NHS England, 
2019; Kumpunen et al., 2017; RACGP, 2016; Collins, 2016).
There were varied views about whether longer and more 
structured guides or shorter, simpler guides were more effi-
cient. Comprehensive and structured conversation guides 
could initially be experienced as cumbersome. However, 
some appreciated the greater guidance they provided, and 
it was generally thought that, used flexibly by experienced 
staff, they did not necessarily lead to longer ACP conver-
sations than shorter guides. Two specific approaches, 
however, were mentioned specifically as having efficiency 
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implications. The Serious Illness Conversation guide from 
Ariadne Labs was praised for its ability to engage time-
pressured clinicians, particularly in acute settings, and for 
its simplicity and brevity (Bernacki et al., 2015). However, 
because it is short and intended for advanced illness, it was 
seen as important it build on earlier ACP conversations. 
Therefore, while the approach may have other positive 
effects, it would not necessarily save staff time. Where they 
were used, group facilitations were thought a cost-effi-
cient way of extending reach. They were generally run by 
staff with expertise in this approach, were suitable for all 
stages of illness and, while rates of document completion 
were lower than in one-to-one conversations, they could 
help to prepare people and simplify later conversations 
and/or decision-making (Lin et al., 2019; Sudore and Fried, 
2010). It seems likely there is scope for group approaches 
to be more widely developed, building on public health 
approaches to end of life care locally (Karapliagkou and 
Kellehear, 2013; NHS England/LGA, 2017).
Existing research shows lack of public awareness of ACP 
and poor understanding of the limitations of medical 
interventions and of palliative and end of life care are sig-
nificant barriers to the uptake of ACP (Hagen et al., 2015; 
Lovell and Yates, 2014; Seymour et al., 2010). Our research 
adds a new dimension to this literature, suggesting, even 
where people take up ACP support, their informational 
and educational needs, and those of family who accom-
pany them, can dominate ACP conversation time, with 
this potentially contributing to persisting inequalities in 
end of life care (Roberts, 2015).
We found only limited use of decision aids, but where used, 
they were thought to help simplify conversations, increase 
equity and support non-physicians to facilitate ACP conver-
sations effectively (Gross et al., 2018). They were thought 
especially useful for commonly misunderstood interven-
tions (e.g., clinically-assisted nutrition and hydration, 
assisted ventilation and cardio-pulmonary resuscitation) 
and for where facilitators may lack specialist clinical knowl-
edge (Gross et al., 2018). This, therefore, seems a useful area 
for further development (Jimenez et al., 2018; Jain et al., 
2015; Aslakson et al., 2015; Butler et al., 2014). However, it is 
also the case relying solely on individual ACP conversations 
to address these informational gaps and misunderstand-
ings may not be the most efficient approach, suggesting a 
need for a strengthened public health approach to end of 
life care, with investments in well-designed, locally relevant 
public education initiatives (Jimenez et al., 2018; Sallnow 
et al., 2016; Karapliagkou and Kellehear, 2013).
Finally, as earlier noted, the provision of ACP support may 
be most usefully understood as a complex intervention, 
with multiple desired outcomes for different stakehold-
ers and inter-connections with a range of other structural 
developments. It is probable that, as these wider system 
changes, designed to reduce dependence on acute medical 
care, are progressed, ACP as a process and the issues cov-
ered by ACP conversations will become better understood 
by health and care staff, patients and families. As a result, 
ACP conversations may well become somewhat less chal-
lenging and time-consuming to facilitate in future.
Further systematic research into these promising 
approaches is needed to determine how they can be 
delivered optimally and to determine their potential 
impacts on efficiency and effectiveness of delivery of ACP 
support. Such research should include the perspectives of 
all stakeholders, including individuals and their families.
Conclusion
System-wide ACP support was understood as a complex 
intervention, with leaders seeking outcomes at a system 
and individual level and for different stakeholders simul-
taneously. The economic case was based primarily on 
achieving value for patients and families, management 
of organisational risk and making best use of resources, 
rather than identifying cost savings. A degree of staff spe-
cialism, team-based delivery, use of decision aids, group-
based facilitations, public health approaches and wider 
system change all offer promising ways of delivering ACP 
support efficiently and effectively at scale.
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